Abstract

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a variety of forms, from single premature ventricular complexes to sustained ventricular tachycardia and fibrillation. Rapid developments have taken place over the past decade in our understanding of these arrhythmias and in our ability to diagnose and treat them. The field of catheter ablation has progressed with the development of new methods and tools, and with the publication of large clinical trials. Therefore, global cardiac electrophysiology professional societies undertook to outline recommendations and best practices for these procedures in a document that will update and replace the 2009 EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. An expert writing group, after reviewing and discussing the literature, including a systematic review and meta-analysis published in conjunction with this document, and drawing on their own experience, drafted and voted on recommendations and summarized current knowledge and practice in the field. Each recommendation is presented in knowledge byte format and is accompanied by supportive text and references. Further sections provide a practical synopsis of the various techniques and of the specific ventricular arrhythmia sites and substrates encountered in the electrophysiology lab. The purpose of this document is to help electrophysiologists around the world to appropriately select patients for catheter ablation, to perform procedures in a safe and efficacious manner, and to provide follow-up and adjunctive care in order to obtain the best possible outcomes for patients with ventricular arrhythmias.

Highlights

  • 1.2 Methods1.1 Document scope and rationaleThe field of electrophysiology has undergone rapid progress in the last decade, with advances both in our understanding of the genesis of ventricular arrhythmias (VAs) and in the technology used to treat them

  • ECG tracings provide important insights regarding location of either the source of focal arrhythmias or the exit site for reentrant ventricular tachycardia (VT); when possible, a 12-lead ECG should be obtained of the target VA(s) (PVC or VT) and be used as a guide for where to concentrate mapping efforts based on published algorithms

  • No randomized studies have demonstrated the benefit of intraprocedural imaging, there are data supporting the use of coronary angiography or intracardiac echocardiography (ICE) to enhance procedural safety for selected cases, allowing for real-time imaging while mapping and ablation are performed [60, 86, 171, 172, 244, 262, 263, 265, 276, 461, 556, 689,690,691,692,693,694,695,696,697]

Read more

Summary

Document scope and rationale

The field of electrophysiology has undergone rapid progress in the last decade, with advances both in our understanding of the genesis of ventricular arrhythmias (VAs) and in the technology used to treat them. LOE A is derived from highquality randomized controlled trials (RCTs); LOE B-R is derived from moderate-quality RCTs; LOE B-NR is derived from well-designed nonrandomized studies; LOE C-LD is derived from randomized or nonrandomized studies with limitations of design or execution; and LOE C-EO indicates that a recommendation was based on expert opinion [7] Unique to this consensus statement is the systematic review commissioned for this document as part of HRS’s efforts to adopt the rigorous methodology required for guideline development. Of public comment, and the entire document underwent rigorous peer review by each of the participating societies and revision by the Chairs, before endorsement

History of ventricular arrhythmia ablation
Mechanisms and basis for catheter ablation of ventricular tachycardia
Scar-related reentry
Reentry in the Purkinje system and ventricular f ibrillation
Definitions
Standard anatomical terminology
III: No Benefit
Indications for catheter ablation
Idiopathic outflow tract ventricular arrhythmia
Idiopathic nonoutflow tract ventricular arrhythmia
Premature ventricular complexes with or without left ventricular dysfunction
Ventricular arrhythmia in ischemic heart disease
Nonischemic cardiomyopathy
Congenital heart disease
Inherited arrhythmia syndromes
Ventricular arrhythmia in hypertrophic cardiomyopathy
Patient selection and preprocedural risk assessment
The PAAINESD risk score
The Seattle Heart Failure Model
Multidisciplinary involvement
Standard 12-lead electrocardiogram
Postinfarction ventricular tachycardia
Epicardial sources
Ventricular tachycardia in nonischemic cardiomyopathy
Bundle branch reentrant ventricular tachycardia
Body surface mapping
Summary
Facilities
Laboratory equipment
Patient safety
Preprocedural imaging
Patient preparation
Anesthesia
Vascular access
Epicardial access
Background
Criteria suggesting epicardial substrate
Epicardial access technique
Epicardial access complications
Intraprocedural hemodynamic support
Intraprocedural anticoagulation
Antibiotic prophylaxis
Fluid balance
Electrophysiological testing
Multielectrode mapping
Activation mapping
Entrainment mapping
The stimulus-QRS interval during entrainment with concealed fusion
How to perform entrainment mapping
Pace mapping
Substrate mapping in sinus rhythm
Intraprocedural imaging during catheter ablation of ventricular arrhythmias
Electroanatomical mapping systems and robotic navigation
Ablation power sources and techniques
Introduction
Unipolar radiofrequency catheter ablation
Contact force sensing
Hypotonic external irrigation
Simultaneous unipolar or simultaneous bipolar radiofrequency delivery
Cryoablation
Transvascular ethanol ablation
Stereotactic radiotherapy
General approach
Right ventricular outflow tract and pulmonary artery
Aortic sinuses of Valsalva
Left ventricular outflow tract and left ventricular summit
Para-Hisian ventricular arrhythmias
Deep intraseptal sites
Ventricular arrhythmias from the tricuspid and mitral annuli
Mapping and ablation of ventricular arrhythmia from the papillary muscles
Specific considerations Several criteria help in diagnosing BBRVT
Idiopathic fascicular reentrant ventricular tachycardia
Nonreentrant fascicular VT
General considerations
Mapping and ablation strategy
Epicardial mapping and ablation
Dilated cardiomyopathy
Ventricular tachycardia ablation in hypertrophic cardiomyopathy
Brugada syndrome
Approach to triggering premature ventricular complexes
Approach to sustained monomorphic ventricular tachycardia
Outcomes
9.10 Arrhythmogenic right ventricular cardiomyopathy
9.10.1 Introduction to the specific disease substrate characteristics
9.10.2 General management
9.10.3 General approach for ablation
9.11 Mapping and ablation in congenital heart disease
9.11.1 Introduction
9.11.2 Mapping and ablation
9.11.3 Outcome after ablation
9.12 Sarcoidosis
9.13.1 Chagas disease
9.13.2 Ventricular tachycardia in Chagas cardiomyopathy
9.14 Miscellaneous diseases and clinical scenarios with ventricular tachycardia
9.14.1 Lamin cardiomyopathy
9.14.2 Left ventricular noncompaction
9.14.3 Congenital left ventricular aneurysms
9.14.4 Left ventricular assist devices
9.15 Surgical therapy
9.16 Sympathetic modulation
9.17 Endpoints of catheter ablation of ventricular tachycardia
9.17.1 Historical perspective
9.17.2 Programmed electrical stimulation
9.17.3 Current ablation strategies and assessment of results
9.17.4 Summary
10.1.1 Postprocedural care
10.1.2 Atrial fibrillation after epicardial ventricular arrhythmia ablation
10.1.3 Postprocedural care
10.2.1 Introduction
10.2.2 Mortality
10.2.3 Acute periprocedural hemodynamic decompensation and cardiogenic shock
10.2.4 Neurological complications
10.2.5 Pericardial complications
10.2.6 Vascular injury
10.2.8 Valve injury
10.2.9 Atrioventricular Block
10.3 Hemodynamic deterioration and proarrhythmia
10.4 Follow-up of patients post catheter ablation of ventricular tachycardia
10.5.1 Introduction
10.5.2 Recurrent arrhythmias
10.5.3 Arrhythmia burden
10.5.4 Ventricular tachycardia storm
10.5.5 Hospitalizations
10.5.6 Patient-reported outcomes
10.5.7 Mortality
11 Training and institutional requirements and competencies
11.1.1 Training requirements
11.1.2 Medical knowledge
11.1.3 Patient care and procedural skills
11.1.4 Systems-based practice
11.1.5 Practice-based learning and improvement
11.1.7 Interpersonal and communications skills
11.2 Institutional requirements for catheter ablation of ventricular tachycardia
11.3 Ventricular tachycardia network and ventricular tachycardia unit
12.1.1 Introduction
12.1.2 Ongoing randomized controlled trials
12.1.4 Future clinical studies
12.2.1 Introduction
12.1.3 Endpoints for prospective clinical trials of ventricular tachycardia ablation
12.2.2 Advances in mapping
12.2.3 Advances in ablation
12.2.4 Advances in patient evaluation
2: Medtronic None None
3: Abbott 5
Findings
2: Abbott
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.